Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolv Technologies Holdings (EVLV) Other Accumulated Expenses (2020 - 2022)

Evolv Technologies Holdings (EVLV) has disclosed Other Accumulated Expenses for 3 consecutive years, with $1.2 million as the latest value for Q1 2022.

  • Quarterly Other Accumulated Expenses changed N/A to $1.2 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Mar 2022, changed N/A year-over-year, with the annual reading at $1.1 million for FY2021, 1810.91% up from the prior year.
  • Other Accumulated Expenses hit $1.2 million in Q1 2022 for Evolv Technologies Holdings, up from $1.1 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.2 million in Q1 2022 to a low of $55000.0 in Q4 2020.
  • Historically, Other Accumulated Expenses has averaged $779750.0 across 3 years, with a median of $918000.0 in 2021.
  • Biggest YoY gain for Other Accumulated Expenses was 1810.91% in 2021; the steepest drop was 1810.91% in 2021.
  • Year by year, Other Accumulated Expenses stood at $55000.0 in 2020, then soared by 1810.91% to $1.1 million in 2021, then rose by 16.84% to $1.2 million in 2022.
  • Business Quant data shows Other Accumulated Expenses for EVLV at $1.2 million in Q1 2022, $1.1 million in Q4 2021, and $785000.0 in Q3 2021.